Feb 22, 2025 In a major regulatory move, India's Central Drug Regulator (CDSCO) have ordered the immediate withdrawal of manufacturing and export permissions for all Tapentadol-Carisoprodol combinations. This decisive action comes in response to growing concerns over their misuse…